Cargando…
Isthmin inhibits glioma growth through antiangiogenesis in vivo
Among glioma treatment strategies, antiangiogenesis emerges as a meaningful and feasible treatment approach for inducing long-term survival. Isthmin is a gene highly expressed in the isthmus of the midbrain–hindbrain organizer in Xenopus, and has recently been identified as a novel angiogenesis inhi...
Autores principales: | Yuan, Bangqing, Xian, Ronghua, Ma, Jianfang, Chen, Yujian, Lin, Chuangan, Song, Yaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432204/ https://www.ncbi.nlm.nih.gov/pubmed/22772605 http://dx.doi.org/10.1007/s11060-012-0910-8 |
Ejemplares similares
-
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma
por: Au, Karolyn, et al.
Publicado: (2015) -
GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo
por: Scheuring, Urban J., et al.
Publicado: (2021) -
Targeting Orthotopic Glioma in Mice with Genetically Engineered Salmonella typhimurium
por: Wen, Min, et al.
Publicado: (2014) -
Bacitracin Inhibits the Migration of U87-MG Glioma Cells via Interferences of the Integrin Outside-in Signaling Pathway
por: Li, Songyuan, et al.
Publicado: (2016) -
The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway
por: Delen, Emre, et al.
Publicado: (2020)